Press Releases about Organon & Co.
From Organon & Co.
Via Business Wire
From Organon & Co.
Via Business Wire
From Organon & Co.
Via Business Wire
From Organon & Co.
Via Business Wire
From Organon & Co.
Via Business Wire
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2023
February 15, 2024
From Organon & Co.
Via Business Wire
Organon affirms 2023 revenue and Adjusted EBITDA guidance and provides 2024 outlook
January 08, 2024
From Organon & Co.
Via Business Wire
Organon To Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 21, 2023
From Organon & Co.
Via Business Wire
Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines
December 18, 2023
From Organon & Co.
Via Business Wire
From Organon & Co.
Via Business Wire
Organon Reports Results for the Third Quarter Ended September 30, 2023
November 02, 2023
From Organon & Co.
Via Business Wire
Organon To Report Third Quarter Results and Host Conference Call on November 2, 2023
October 19, 2023
From Organon & Co.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.